1 00:00:02,520 --> 00:00:09,960 Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report, 2 00:00:10,280 --> 00:00:13,360 Speaker 1: your roundup of companies making moves in the stock market, 3 00:00:13,680 --> 00:00:15,880 Speaker 1: harnessing the power of Bloomberg data. 4 00:00:16,480 --> 00:00:18,640 Speaker 2: Let's take a look at some stocks in the move today. 5 00:00:18,880 --> 00:00:24,279 Speaker 2: Alexisfus it's a podcast and it's stock movers. It's a 6 00:00:24,360 --> 00:00:28,160 Speaker 2: spicy stock movers Alexis Stock. Yeah, I like that spicy. 7 00:00:28,200 --> 00:00:31,480 Speaker 2: I'm going to start with a spicy want, Appellas Pharmaceuticals 8 00:00:31,520 --> 00:00:33,800 Speaker 2: because this stock has more than doubled here in the 9 00:00:33,840 --> 00:00:36,440 Speaker 2: pre market. It's up one hundred and thirty six percent. 10 00:00:36,840 --> 00:00:37,680 Speaker 2: And here's why. 11 00:00:38,040 --> 00:00:41,159 Speaker 3: Biogen is going to buy a Pelas for forty one 12 00:00:41,200 --> 00:00:44,479 Speaker 3: dollars a share. That's more than double the company's closing 13 00:00:44,520 --> 00:00:48,320 Speaker 3: price yesterday. Before this deal, A Pelas's stock was down 14 00:00:48,440 --> 00:00:51,839 Speaker 3: thirty two percent. So in this bio Biogen's going to 15 00:00:51,840 --> 00:00:55,320 Speaker 3: get two approved drugs. Appelas's best selling medicine that treats 16 00:00:55,320 --> 00:00:58,240 Speaker 3: an immune disorder that's a leading cause of blindness. That 17 00:00:58,320 --> 00:01:00,800 Speaker 3: drug generated more than half a billion dollars in revenue 18 00:01:00,840 --> 00:01:03,720 Speaker 3: last year, and another drug that treats both a blood 19 00:01:03,720 --> 00:01:06,600 Speaker 3: disorder and a rare kidney disease. And we know that 20 00:01:06,680 --> 00:01:09,960 Speaker 3: Biogen has really been focusing on kidney disease. It's been 21 00:01:09,959 --> 00:01:12,400 Speaker 3: an area of focus for the company. So Biogen says 22 00:01:12,400 --> 00:01:14,360 Speaker 3: this deal is going to provide some near term revenue 23 00:01:14,360 --> 00:01:17,120 Speaker 3: growth that it fits with its strategy. And the CEO said, 24 00:01:17,120 --> 00:01:19,560 Speaker 3: you know, they've been studying a Pelas for over a 25 00:01:19,640 --> 00:01:21,880 Speaker 3: year now. They thought it was overvalued by the market. 26 00:01:22,120 --> 00:01:24,039 Speaker 3: They say, they think what they are paying for this 27 00:01:24,120 --> 00:01:27,200 Speaker 3: company is quote a good price. But shares of a 28 00:01:27,280 --> 00:01:29,279 Speaker 3: Pellas of one hundred and thirty six percent. 29 00:01:29,600 --> 00:01:31,880 Speaker 2: There's a lot of m and out there. Let's do 30 00:01:32,000 --> 00:01:34,360 Speaker 2: enough for this and a lot of biotech kind of 31 00:01:34,560 --> 00:01:36,399 Speaker 2: exactly names I can't pronounce. 32 00:01:37,319 --> 00:01:39,720 Speaker 3: I'm not going to that's what we just say. It's 33 00:01:39,720 --> 00:01:41,280 Speaker 3: a drug, it's a medicine. 34 00:01:42,040 --> 00:01:45,839 Speaker 2: Brave this with Nathan, What did I all the different 35 00:01:45,920 --> 00:01:46,400 Speaker 2: names say. 36 00:01:46,400 --> 00:01:48,720 Speaker 3: Crazy that you were listening at so early in the morning. 37 00:01:48,960 --> 00:01:54,520 Speaker 3: Thank you so Sentessa so sticking with this pharma situation, 38 00:01:54,600 --> 00:01:57,400 Speaker 3: this theme here, We've got shares of Sintessa up forty 39 00:01:57,440 --> 00:02:01,800 Speaker 3: six percent. Eli Lilly will pay thirty eight dollars a 40 00:02:01,840 --> 00:02:04,600 Speaker 3: share in cash for UK based sent Tessa. That's a 41 00:02:04,680 --> 00:02:08,160 Speaker 3: thirty eight percent premium to yesterday's closing price. And here's 42 00:02:08,320 --> 00:02:11,720 Speaker 3: something interesting the way they structured this deal, sent Tessa 43 00:02:11,720 --> 00:02:15,320 Speaker 3: investors are going to receive CVRs. These are contingent value 44 00:02:15,400 --> 00:02:18,040 Speaker 3: rights worth up to an additional nine dollars a share, 45 00:02:18,080 --> 00:02:21,480 Speaker 3: bringing the total deal to about seven point eight billion dollars. 46 00:02:21,480 --> 00:02:23,800 Speaker 3: And those CVRs are going to be contingent upon the 47 00:02:23,840 --> 00:02:27,600 Speaker 3: company hitting certain milestones right including future FDA approvals for 48 00:02:27,680 --> 00:02:31,200 Speaker 3: some drugs. Eli Lilly is up just about one percent, 49 00:02:31,200 --> 00:02:33,960 Speaker 3: but again sent Tessa up forty six percent on that deal. 50 00:02:34,320 --> 00:02:36,840 Speaker 3: And well, let's move over to technology and move out 51 00:02:36,840 --> 00:02:39,679 Speaker 3: of pharma space for a moment. Talk about Marvel Technology. 52 00:02:40,080 --> 00:02:42,079 Speaker 3: This stock is up nine percent here in the pre 53 00:02:42,200 --> 00:02:46,120 Speaker 3: market after Nvidia said it's going to invest two billion 54 00:02:46,200 --> 00:02:49,560 Speaker 3: dollars in the chips and networking companies. So in Video 55 00:02:49,600 --> 00:02:51,560 Speaker 3: is going to take a stake in Marvel. It's part 56 00:02:51,600 --> 00:02:55,560 Speaker 3: of a collaboration that will allow customers to use components 57 00:02:55,560 --> 00:03:00,320 Speaker 3: from both of these companies to develop semi custom AI infrastructure. 58 00:03:00,760 --> 00:03:03,239 Speaker 3: So it's a deal that Wall Street seems to be applauding, 59 00:03:03,280 --> 00:03:05,600 Speaker 3: with Marvel up, like I said, about nine percent here 60 00:03:05,720 --> 00:03:07,200 Speaker 3: in the pre market. Guys. 61 00:03:07,760 --> 00:03:11,960 Speaker 1: The Stockmovers report from Bloomberg Radio check back with us 62 00:03:12,040 --> 00:03:14,840 Speaker 1: throughout the day for the latest roundup of companies making 63 00:03:14,919 --> 00:03:18,520 Speaker 1: news on Wall Street, and for the latest market moving headlines. 64 00:03:18,720 --> 00:03:22,720 Speaker 1: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg 65 00:03:22,800 --> 00:03:25,840 Speaker 1: dot com, and on Applecarplay and Android Auto with the 66 00:03:25,880 --> 00:03:27,240 Speaker 1: Bloomberg Business app.